芪参益气滴丸联合替米沙坦治疗早期糖尿病肾病疗效及其对氧化应激指标的影响(3)
第1页 |
参见附件。
[5] 王颖辉,赵进喜,王世东,等.糖尿病肾病不同分期证候演变研究[J].中华中医药杂志,2012,27(10):2687-2690.
[6] Brownlee M. Biochemistry and molecular cell biology of diabetic complications[J]. Nature,2001,414(6865):813-820.
[7] 孙文,冯丽园,赵宗江,等.三七总皂苷干预糖尿病肾病大鼠氧化应激及足细胞凋亡机制的实验研究[J].中华中医药杂志,2011,26(5):1062- 1067.
[8] Kumar S, Prasad S, Sitasawad SL. Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats[J]. PLoS One,2013,8(7):e67009.
[9] Carnevale R, Iuliano L, Nocella C, et al. Relationship between platelet and urinary 8-Iso-PGF2α levels in subjects with different degrees of NOX2 regulation[J]. J Am Heart Assoc,2013,2(3):e000198.
[10] 柯斌,师林,孙保国,等.芪参益气滴丸治疗女性冠心病稳定性心绞痛的临床研究[J].中成药,2012,34(9):1660-1663.
[11] 关秀军,邓斌,周旭军,等.芪参益气滴丸对慢性心衰患者心室重构及炎性因子的影响[J].时珍国医国药,2013,24(3):681-682.
[12] Alter ML, Ott IM, von Websky K, et al. DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach fordiabetic nephropathy[J]. Kidney Blood Press Res, 2012,36(1):119-130.
(收稿日期:2014-02-28)
(修回日期:2014-04-01;编辑:陈静)
您现在查看是摘要介绍页,详见PDF附件。